Melanocortin-4 receptor binding compounds and methods of use thereof

Details for Australian Patent Application No. 2004320025 (hide)

International Classifications

Event Publications

19 January 2006 Application Open to Public Inspection

Published as AU-A-2004320025

19 January 2006 PCT application entered the National Phase

29 May 2008 Alteration of Name

The name of the applicant has been altered to Ore Pharmaceuticals Inc. 2005

11 December 2008 Corrigenda

PCT applications that have entered the National Phase - Name Index Under the Name Ore Pharmaceuticals Inc., Application No. 2004320025, under INID (43), correct the date to 22 December 2005

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.